| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 438 | 22.630 | 91.737 | 102.772 | 92.513 | 87.289 | 94.453 |
| Total Income - EUR | - | - | - | 1.312 | 24.861 | 98.597 | 102.774 | 104.122 | 92.293 | 94.512 |
| Total Expenses - EUR | - | - | - | 2.462 | 25.514 | 94.685 | 100.732 | 102.987 | 90.274 | 102.048 |
| Gross Profit/Loss - EUR | - | - | - | -1.149 | -653 | 3.912 | 2.042 | 1.135 | 2.019 | -7.535 |
| Net Profit/Loss - EUR | - | - | - | -1.162 | -909 | 3.178 | 1.415 | 92 | 1.136 | -9.390 |
| Employees | - | - | - | 1 | 1 | 1 | 2 | 3 | 3 | 2 |
Check the financial reports for the company - Yakys Biomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 124 | 122 | 157 | 0 | 0 | 804 | 560 |
| Current Assets | - | - | - | 4.572 | 7.191 | 24.569 | 17.515 | 16.716 | 22.378 | 14.292 |
| Inventories | - | - | - | 4.438 | 7.059 | 21.358 | 16.878 | 14.912 | 18.876 | 12.842 |
| Receivables | - | - | - | 0 | 0 | 2.720 | 378 | 378 | 164 | 9 |
| Cash | - | - | - | 134 | 132 | 491 | 258 | 1.426 | 3.338 | 1.441 |
| Shareholders Funds | - | - | - | -1.119 | -2.006 | 1.210 | 2.598 | 2.699 | 3.827 | -5.584 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 5.815 | 9.319 | 23.517 | 14.917 | 14.016 | 19.355 | 20.436 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Yakys Biomed S.r.l.